Literature DB >> 35754286

A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group Meeting.

Ali Al Shehri1, Abdullah Al-Asmi2, Abdullah Mohammed Al Salti3, Abubaker Almadani4, Ali Hassan5, Ahmed K Bamaga6,7, Edward J Cupler8, Jasem Al-Hashel9,10, Majed M Alabdali11, Mohammed H Alanazy12, Suzan Noori13.   

Abstract

Pompe disease is a rare, metabolic, autosomal recessive disorder. Early diagnosis is critical for progressive Pompe disease as delays can significantly alter the clinical course of the disease. Diagnostic modalities, including dried blood spot testing and genetic testing, are available and are effective for diagnosing patients with late-onset Pompe disease (LOPD). However, clinicians face numerous clinical challenges related to the diagnosis of the disease. Two expert group committee meetings, involving 11 experts from the United Arab Emirates, Kuwait, the Kingdom of Saudi Arabia, and Oman, were convened in October 2019 and November 2020 respectively to develop a uniform diagnostic algorithm for the diagnosis of pediatric and adult LOPD in the Arabian Peninsula region. During the first meeting, the specialty-specific clinical presentation of LOPD was defined. During the second meeting, a diagnostic algorithm was developed after a thorough validation of clinical presentation or symptoms, which was performed with the aid of existing literature and expert judgement. A consensus was reached on the diagnostic algorithm for field specialists, such as neurologists, rheumatologists, general practitioners/internal medicine specialists, orthopedic specialists, and pulmonologists. This specialty-specific diagnostic referral algorithm for pediatric and adult LOPD will guide clinicians in the differential diagnosis of LOPD.

Entities:  

Keywords:  Arabian Peninsula region; Late-onset Pompe disease; acid alpha-glucosidase; dried blood spot

Mesh:

Year:  2022        PMID: 35754286      PMCID: PMC9535603          DOI: 10.3233/JND-220819

Source DB:  PubMed          Journal:  J Neuromuscul Dis


  64 in total

1.  Prevalence of late-onset pompe disease in Portuguese patients with diaphragmatic paralysis - DIPPER study.

Authors:  M J Guimarães; J C Winck; B Conde; A Mineiro; M Raposo; J Moita; A Marinho; J M Silva; N Pires; S André; C Loureiro
Journal:  Rev Port Pneumol (2006)       Date:  2017-05-09

2.  36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry.

Authors:  Olivier Scheidegger; Daniela Leupold; Rafael Sauter; Oliver Findling; Kai Michael Rösler; Thomas Hundsberger
Journal:  J Neurol       Date:  2018-09-19       Impact factor: 4.849

3.  Central nervous system involvement in late-onset Pompe disease: clues from neuroimaging and neuropsychological analysis.

Authors:  O Musumeci; S Marino; F Granata; R Morabito; L Bonanno; T Brizzi; V Lo Buono; F Corallo; M Longo; A Toscano
Journal:  Eur J Neurol       Date:  2018-11-15       Impact factor: 6.089

4.  Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling.

Authors:  M G Ausems; J Verbiest; M P Hermans; M A Kroos; F A Beemer; J H Wokke; L A Sandkuijl; A J Reuser; A T van der Ploeg
Journal:  Eur J Hum Genet       Date:  1999-09       Impact factor: 4.246

5.  Impact of late-onset Pompe disease on participation in daily life activities: evaluation of the Rotterdam Handicap Scale.

Authors:  M L C Hagemans; P Laforêt; W J C Hop; I S J Merkies; P A Van Doorn; A J J Reuser; A T Van der Ploeg
Journal:  Neuromuscul Disord       Date:  2007-05-01       Impact factor: 4.296

Review 6.  Exercise and muscular dystrophy: implications and analysis of effects on musculoskeletal and cardiovascular systems.

Authors:  Matthew S Barnabei; Joshua M Martindale; DeWayne Townsend; Joseph M Metzger
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

7.  Consanguineous marriages, pearls and perils: Geneva International Consanguinity Workshop Report.

Authors:  Hanan Hamamy; Stylianos E Antonarakis; Luigi Luca Cavalli-Sforza; Samia Temtamy; Giovanni Romeo; Leo P Ten Kate; Robin L Bennett; Alison Shaw; Andre Megarbane; Cornelia van Duijn; Heli Bathija; Siv Fokstuen; Eric Engel; Joel Zlotogora; Emmanouil Dermitzakis; Armand Bottani; Sophie Dahoun; Michael A Morris; Steve Arsenault; Mona S Aglan; Mubasshir Ajaz; Ayad Alkalamchi; Dhekra Alnaqeb; Mohamed K Alwasiyah; Nawfal Anwer; Rawan Awwad; Melissa Bonnefin; Peter Corry; Lorraine Gwanmesia; Gulshan A Karbani; Maryam Mostafavi; Tommaso Pippucci; Emmanuelle Ranza-Boscardin; Bruno Reversade; Saghira M Sharif; Marieke E Teeuw; Alan H Bittles
Journal:  Genet Med       Date:  2011-09       Impact factor: 8.822

8.  Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function.

Authors:  Sebastián Figueroa-Bonaparte; Sonia Segovia; Jaume Llauger; Izaskun Belmonte; Irene Pedrosa; Aída Alejaldre; Mercè Mayos; Guillermo Suárez-Cuartín; Eduard Gallardo; Isabel Illa; Jordi Díaz-Manera
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

9.  A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan.

Authors:  Yasuyuki Fukuhara; Naoko Fuji; Narutoshi Yamazaki; Asami Hirakiyama; Tetsuharu Kamioka; Joo-Hyun Seo; Ryuichi Mashima; Motomichi Kosuga; Torayuki Okuyama
Journal:  Mol Genet Metab Rep       Date:  2017-10-31

Review 10.  Pompe Disease: New Developments in an Old Lysosomal Storage Disorder.

Authors:  Naresh K Meena; Nina Raben
Journal:  Biomolecules       Date:  2020-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.